Cadrenal Therapeutics, Inc..
CVKD.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
Cadrenal Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for cardiovascular diseases. Their primary focus is on developing tecarfarin, a novel anti-coagulant drug candidate, for the prevention of systemic thromboembolism (blood clots) in pa...Show More
Better Health for All
0
No evidence available to assess Cadrenal Therapeutics, Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
No evidence available to assess Cadrenal Therapeutics, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
Cadrenal Therapeutics, Inc. had 4 employees as of December 31, 2024.
1
Due to this small workforce size, the company does not provide data for most KPIs related to fair pay and worker respect. Specifically, there is no data on living wage coverage, collective bargaining, safety incidents, pay equity, worker engagement, employee turnover, insecure contracts, or health insurance coverage.
2
The company's annual report also states that a CEO to median employee pay ratio is not applicable.
3
Fair Trade & Ethical Sourcing
0
The provided article discusses research on anticoagulation burden for LVAD patients and contains no information or data relevant to Cadrenal Therapeutics, Inc.'s fair trade practices, ethical sourcing, supply chain management, or any of the specific KPIs for this value.
1
Honest & Fair Business
-40
Cadrenal Therapeutics has a formal Whistleblower Policy, approved in October 2022, which allows for confidential and anonymous reporting of accounting, auditing, and code of conduct concerns via an ethics hotline.
1
The policy includes anti-retaliation measures, and the Audit Committee is responsible for reviewing and investigating reports.
2
The company also has an anti-corruption policy that explicitly addresses the Foreign Corrupt Practices Act (FCPA), prohibiting gifts to foreign officials or political candidates to obtain or retain business, and specifically bans cash or cash equivalents.
3
However, there is no evidence of training frequency or effectiveness metrics for this policy.
Kind to Animals
0
Cadrenal Therapeutics, Inc. is a biopharmaceutical company developing a drug, tecarfarin, which has undergone animal studies using canine and rabbit models.
1
However, the provided articles do not contain specific, concrete data points regarding the company's animal testing policy, the volume of animals used, or any investment in animal-free alternatives.
2
There is also no information on cruelty-free certifications, humane certifications for operations, wildlife conservation impact, ethical input substitution, supplier audits for welfare, cage-free sourcing, animal agriculture ethics, animal-free R&D collaboration, or public policy engagement related to animal welfare.
3
No War, No Weapons
0
No evidence available to assess Cadrenal Therapeutics, Inc. on No War, No Weapons.
Planet-Friendly Business
0
The provided articles explicitly state that no data relevant to planet-friendly business practices, such as emissions, renewable energy usage, waste diversion, or other sustainability metrics, is available for CVKD.US.
1
Therefore, no KPIs in this category can be scored.
Respect for Cultures & Communities
0
The provided article focuses exclusively on the clinical trials, safety profile, and regulatory designations for Cadrenal Therapeutics, Inc.'s drug candidate, tecarfarin. It details various trial phases, subject numbers, and clinical outcomes. No information regarding the company's engagement with communities, cultural impact, local employment, procurement, or any other aspect related to the 'Respect for Cultures & Communities' value is present in the article.
1
Safe & Smart Tech
0
The company has reported no data breach incidents to date.
1
Its privacy statement, effective September 22, 2022, allows users to contact the company to correct, change, or opt-out of communications.
2
The company has a cyber risk management protocol in place and conducts annual assessments of cyber risks and develops mitigation plans.
3
The company's policies are designed to comply with federal securities laws, SEC regulations, NASDAQ Stock Market rules, and the Sarbanes-Oxley Act, and it states that it meets legal, regulatory, insurance, security, and processing requirements.
4
Zero Waste & Sustainable Products
0
No specific, concrete data points related to waste management, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audits, zero waste certification, waste disposal violations, material efficiency, packaging to product ratio, waste reduction targets, supplier waste requirements, or customer waste education were found in the provided articles.
1
All articles contained only placeholder text and explicitly stated that no relevant data could be extracted.
2